| Oct 8 |
US Venture Capital Opens Path to Funding for China Biotech Firms
|
| Oct 8 |
GSK Arexvy protects from RSV over three full seasons
|
| Oct 8 |
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
|
| Oct 8 |
Why Pfizer Will Find It Hard to Appease Its Activist Investor
|
| Oct 7 |
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
|
| Oct 7 |
Starboard Value takes $1 billion stake in Pfizer: Reports
|
| Oct 7 |
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
|
| Oct 7 |
U.K. court rules in Pfizer's favor in GSK RSV vaccine dispute: report
|
| Oct 7 |
Millions urged to delete data from mail-order DNA test maker
|
| Oct 4 |
GSK, Sanofi, CSL said to win $72M U.S. bird flu vaccine contract (update)
|
